1. Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy
   Sedigheh Shahvali et al, 2023, Drug Delivery and Translational Research CrossRef
2. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment
   Tongtong Wei et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
3. Stromal Barrier-Dismantled Nanodrill-Like and Cancer Cell-Targeted pH-Responsive Polymeric Micelles for Further Enhancing the Anticancer Efficacy of Doxorubicin
   Chuhang Zhou et al, 2021, ACS Biomaterials Science & Engineering CrossRef
4. Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment
   Yasushi Shintani et al, 2023, Cancers CrossRef
5. Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer
   Zhaoye Wu et al, 2022, Nuclear Medicine Communications CrossRef
6. Dendritic cells infected with recombinant adenoviral vector encoding mouse fibroblast activation protein‐α and human livin α exert an antitumor effect against Lewis lung carcinoma in mice
   Zaiting Ye et al, 2023, Immunity, Inflammation and Disease CrossRef
7. Stromal modulation strategies to improve immunotherapy response in cancer
   Kai Shi, 2022, Engineering Technologies and Clinical Translation CrossRef